Clinical Trial Update: Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating co-treatment with GnRH analogs to protect ovarian reserve in young women receiving alkylating chemotherapy for cancer; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Ewing Sarcoma
• Lymphoma
• Osteosarcoma
• Sarcoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cancer, Toxicity Due to Chemotherapy | Phase 2, Phase 3 | Status: UNKNOWN